| Title: | ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress |
| Authors: | Guallar, D Fuentes-Iglesias, A Souto, Y Ameneiro, C Freire-Agulleiro, O Pardavila, JA Escudero, A Garcia-Outeiral, V Moreira, T Saenz, C Xiong, H Liu, DB Xiao, SD Hou, Y Wu, K Torrecilla, D Hartner, JC Blanco, MG Lee, LJ Lopez, M Walkley, CR Wang, JL Fidalgo, M |
| Issue Year: | 2020 |
| Publisher | CELL PRESS |
| Series | CELL STEM CELL: |
| Abstract | Type 17 immune responses, typified by the production of the cytokines IL-17A and IL-17F, have been implicated in the development of type 1 diabetes in animal models and human patients, however the underlying pathogenic mechanisms have not been clearly elucidated. While previous studies show that IL-17A enhances inflammatory gene expression and cell death in mouse beta -cells and human islets, the function of IL-17F in pancreatic beta -cells is completely untested to date. Here we show that IL-17F exhibits potent pathogenic effects in mouse beta -cell lines and islets. IL-17F signals via the IL-17RA and -RC subunits in beta -cells and in combination with other inflammatory cytokines induces expression of chemokine transcripts, suppresses the expression of beta -cell identity genes and impairs glucose stimulated insulin secretion. Further IL-17F induces cell death in primary mouse islets. This occurs via Jnk, p38 and NF-kappa B dependent induction of Nos2 and is completely ablated in the presence of an inducible nitric oxide synthase (iNOS) inhibitor. Together these data indicate that IL-17F possesses similar pathogenic activities to IL-17A in mouse beta -cell lines and islets and is likely to be a type 17 associated pathogenic factor in type 1 diabetes. |
| URI: | https://publications.svi.edu.au/publications/7077 |
| Other Identifiers | 10.1016/j.stem.2020.04.016 |
| Publication type | Article |